adenosine diphosphate has been researched along with tirofiban in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (25.00) | 18.2507 |
| 2000's | 20 (71.43) | 29.6817 |
| 2010's | 1 (3.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duggan, ME; Egbertson, MS; Halczenko, W; Hartman, GD; Laswell, WL; Lynch, RJ; Manno, PD; Naylor, AM; Smith, RL; Zhang, G | 1 |
| Cook, JJ; Holahan, MA; Lynch, JJ; Lynch, RJ; Mellott, MJ; Ramjit, DR; Sitko, GR; Stabilito, II; Stranieri, MT; Zhang, G | 1 |
| Chang, CT; Duggan, ME; Egbertson, MS; Gould, RJ; Halczenko, W; Hartman, GD; Laswell, WL; Lynch, JJ; Lynch, RJ; Manno, PD | 1 |
| Bruttger, O; Cook, NS; Hagenbach, A; Pally, C | 1 |
| Aoki, T; Honda, S; Okubo, M; Seki, J; Senzaki, K; Takahashi, F; Takasugi, H; Tanaka, A; Tomiyama, Y | 1 |
| Faul, JD; Huang, J; Lucchesi, BR; Rebello, SS | 1 |
| Holmes, MB; Schneider, DJ; Sobel, BE | 1 |
| Chen, JC; Ishimaru, S; Powell, LL; Serna, DL; Wang, D; Wilson, SE; Yomo, T | 1 |
| Rodrigues, HL | 1 |
| Proimos, G | 1 |
| Ito, H; Kimura, Y; Ozeki, Y; Sudo, T | 1 |
| Schrör, K; Weber, AA | 1 |
| Jacobs, C; Kelm, M; Meila, D; Scharf, RE; Schrör, K; Strauer, BE; Weber, AA; Weber, S; Zotz, RB | 2 |
| Bowbrick, VA; Mikhailidis, DP; Stansby, G | 1 |
| Blazicek, H; Domanovits, H; Galehr, E; Jilma, B; Jilma-Stohlawetz, P; Mayr, F; Reiter, RA | 1 |
| Bolton, ED; Braunstein, JB; Chiles, KA; Faraday, N; Gerstenblith, G; Heldman, AW; Schulman, SP | 1 |
| Katori, N; Kelly, AB; Levy, JH; Sato, N; Szlam, F; Tanaka, KA | 1 |
| Domanovits, H; Frossard, M; Fuchs, I; Hsieh, K; Jilma, B; Laggner, AN; Leitner, JM; Losert, H; Schreiber, W; Vlcek, M | 1 |
| Ilveskero, S; Lassila, R | 1 |
| Matzdorff, A; Voss, R | 1 |
| Baumann, PQ; Schneider, DJ; Sobel, BE; Whitaker, DA | 1 |
| Holmes, CE; Madsen, NJ; Schneider, DJ; Serrano, FA; Sobel, BE | 1 |
| Jagroop, IA; Mikhailidis, DP | 1 |
| Ciborowski, M; Dobrzycki, S; Rusak, T; Tomasiak, M; Winnicka, K | 1 |
| Basani, RB; Bennett, JS; Degrado, WF; Kowalska, MA; Poncz, M; Soto, CS; Thornton, MA; Zhu, H | 1 |
| Alam, M; Bobek, J; Delarosa, A; Dokainish, H; Gonzalez, R; Lakkis, N | 1 |
| Dai, K; Li, S; Liu, G; Shi, Q; Wang, Y; Wang, Z; Zhang, W | 1 |
2 review(s) available for adenosine diphosphate and tirofiban
| Article | Year |
|---|---|
[Update on the treatment with platelet antiaggregation agents].
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Arachidonic Acid; Cell Membrane; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prostaglandin-Endoperoxide Synthases; Thromboxane A2; Tirofiban; Tyrosine | 2001 |
Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors.
Topics: Abciximab; Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Antibodies, Monoclonal; Anticoagulants; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Interactions; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Oligopeptides; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Proteins; Receptors, Thrombin; Thrombin; Tirofiban; Tyrosine | 2001 |
3 trial(s) available for adenosine diphosphate and tirofiban
| Article | Year |
|---|---|
Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjects.
Topics: Adenosine Diphosphate; Adult; Dose-Response Relationship, Drug; Eptifibatide; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Peptides; Platelet Aggregation Inhibitors; Protein Binding; Tirofiban; Tyrosine | 1999 |
Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin.
Topics: Abciximab; Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Aspirin; Collagen; Cross-Over Studies; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Male; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 2003 |
Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Aged; Angina, Unstable; Arachidonic Acid; Aspirin; Blood Platelets; C-Reactive Protein; Cell Aggregation; Drug Resistance; Eptifibatide; Female; Heparin; Humans; Leukocytes; Male; Middle Aged; Monocytes; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Neutrophils; Patient Selection; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Receptors, Thrombin; Recurrence; ROC Curve; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2004 |
23 other study(ies) available for adenosine diphosphate and tirofiban
| Article | Year |
|---|---|
Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Binding Sites; Endothelium, Vascular; Fibrinogen; Humans; Molecular Sequence Data; Molecular Structure; Oligopeptides; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Tirofiban; Tyrosine; Umbilical Veins | 1992 |
Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
Topics: Adenosine Diphosphate; Animals; Coronary Circulation; Dogs; Female; Hemostasis; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Streptokinase; Thrombosis; Tirofiban; Tissue Plasminogen Activator; Tyrosine | 1995 |
Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Animals; Dogs; Endothelium, Vascular; Humans; Kinetics; Models, Molecular; Molecular Sequence Data; Molecular Structure; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Structure-Activity Relationship; Templates, Genetic; Tirofiban; Tyrosine; Umbilical Veins | 1994 |
The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
Topics: Acetates; Adenosine Diphosphate; Administration, Oral; Animals; Benzamides; Bleeding Time; Dogs; Drug Administration Routes; Duodenum; Female; Fibrinolytic Agents; Guinea Pigs; Injections, Intravenous; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Reproducibility of Results; Species Specificity; Tirofiban; Tyrosine | 1993 |
Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Apyrase; Aspirin; Blood Platelets; Calcium; Cyclooxygenase Inhibitors; Dipeptides; Fibrinogen; Humans; Ion Transport; Peptide Fragments; Phenylacetates; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Signal Transduction; Sulfonamides; Thrombin; Thromboxane A2; Thromboxane B2; Tirofiban; Tyrosine | 1998 |
Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition.
Topics: Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arachidonic Acid; Bleeding Time; Blood Flow Velocity; Blood Platelets; Carotid Arteries; Carotid Artery Thrombosis; Citrates; Dogs; Dose-Response Relationship, Drug; Female; Heparin; Immunoglobulin Fab Fragments; Male; Mesylates; Mice; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine | 1999 |
Glycoprotein IIb/IIIa receptor inhibitor attenuates platelet aggregation induced by thromboxane A2 during in vitro nonpulsatile ventricular assist circulation.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Analysis of Variance; Anti-Bacterial Agents; Blood Platelets; Cell Degranulation; Collagen; Heart-Assist Devices; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Ristocetin; Thromboxane A2; Tirofiban; Tyrosine | 2000 |
Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
Topics: Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Aspirin; Blood Coagulation; Blood Platelets; Cilostazol; Collagen; Dipyridamole; Filtration; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Pressure; Tetrazoles; Time Factors; Tirofiban; Tyrosine | 2001 |
Differential inhibition of adenosine diphosphate- versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different glycoprotein IIb/IIIa activation kinetics.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Biotinylation; Depression, Chemical; Dose-Response Relationship, Drug; Eptifibatide; Fibrinogen; Humans; Immunoglobulin Fab Fragments; Kinetics; Peptides; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Proteins; Receptors, Thrombin; Tirofiban; Tyrosine | 2001 |
Low incidence of paradoxical platelet activation by glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Antigens, Human Platelet; Case-Control Studies; Coronary Artery Disease; Eptifibatide; Female; Genotype; Humans; Immunoglobulin Fab Fragments; Incidence; Integrin beta3; Male; Middle Aged; P-Selectin; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Tirofiban; Tyrosine | 2002 |
No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; Antigens, Human Platelet; Blood Platelets; Fibrinogen; Genotype; Humans; Immunoglobulin Fab Fragments; Integrin beta3; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Tirofiban; Tyrosine | 2002 |
Value of thromboelastography in the assessment of platelet function.
Topics: Adenosine Diphosphate; Aspirin; Humans; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Sensitivity and Specificity; Thrombelastography; Tirofiban; Tyrosine | 2003 |
Effects of tirofiban on haemostatic activation in vitro.
Topics: Adenosine Diphosphate; Blood Coagulation; Dose-Response Relationship, Drug; Hemostasis; Heparin; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Tirofiban; Tyrosine | 2004 |
Platelet function predicts myocardial damage in patients with acute myocardial infarction.
Topics: Abciximab; Adenosine Diphosphate; Aged; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cardiovascular Agents; Clopidogrel; Collagen; Comorbidity; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Ticlopidine; Tirofiban; Tyrosine; von Willebrand Factor | 2004 |
Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists.
Topics: Abciximab; Adenosine Diphosphate; Antibodies, Monoclonal; C-Reactive Protein; Chromatography, Gel; Coagulants; Collagen; Dose-Response Relationship, Drug; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Models, Statistical; Peptides; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Tirofiban; Tyrosine | 2006 |
Upregulation of GP IIb/IIIa receptors during platelet activation: influence on efficacy of receptor blockade.
Topics: Abciximab; Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Anticoagulants; Binding Sites; Blood Platelets; Female; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Models, Statistical; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Time Factors; Tirofiban; Tyrosine; Up-Regulation | 2006 |
Variation in the ability of glycoprotein IIb-IIIa antagonists to exert and maintain their inhibitory effects on the binding of fibrinogen.
Topics: Adenosine Diphosphate; Aged; Binding, Competitive; Blood Platelets; Clopidogrel; Coronary Artery Disease; Data Interpretation, Statistical; Eptifibatide; Fibrinogen; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Iodine Radioisotopes; Male; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Benzothiazoles; Blood Platelets; Coronary Disease; Crotalid Venoms; Flow Cytometry; Fluorescent Dyes; Hemostatics; Humans; Lectins, C-Type; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Quinolines; Thrombin; Tirofiban; Tyrosine | 2007 |
The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
Topics: Adenosine Diphosphate; Blood Platelets; Cell Shape; Fibrinogen; Fibrinolytic Agents; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Fibrinogen; Serotonin; Tirofiban; Tyrosine | 2008 |
The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Coagulation Factors; Blood Platelets; Calcium Signaling; Collagen; Cytoplasmic Granules; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Lysosomes; Male; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Sus scrofa; Thrombelastography; Thrombin; Tirofiban; Tyrosine | 2008 |
Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Animals; Cell Line; Conserved Sequence; Cricetinae; Eptifibatide; Fibrinogen; Humans; Mice; Molecular Sequence Data; Peptides; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Rats; Recombinant Proteins; Sequence Alignment; Tirofiban; Tyrosine | 2009 |
In vitro inhibition of platelet aggregation in response to increasing concentrations of tirofiban in patients with significant renal insufficiency.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Chi-Square Distribution; Creatinine; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet-Rich Plasma; Renal Insufficiency; Risk Factors; Tirofiban; Tyrosine | 2009 |
Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Topics: Actin Cytoskeleton; Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Calcium; Chelating Agents; Contractile Proteins; Egtazic Acid; Filamins; Hemostasis; Humans; Hypergravity; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microfilament Proteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Protein Binding; Ristocetin; Thrombosis; Time Factors; Tirofiban; Tyrosine; Weightlessness Simulation | 2010 |